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INTRODUCTION
Alzheimer’s disease (AD), a devastating neurodegenerative 
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Obesity-related metabolic disorders can affect not only systemic health but also brain function. Recent studies have elucidated that 
amyloid beta deposition cannot satisfactorily explain the development of Alzheimer’s disease (AD) and that dysregulation of glu-
cose metabolism is a critical factor for the sporadic onset of non-genetic AD. Identifying the pathophysiology of AD due to changes 
in brain metabolism is crucial; however, it is limited in measuring changes in brain cognitive function due to metabolic changes 
in animal models. The touchscreen-based automated battery system, which is more accurate and less invasive than conventional 
behavioral test tools, is used to assess the cognition of mice with dysregulated metabolism. This system was introduced in humans 
to evaluate cognitive function and was recently back-translated in monkeys and rodents. We used outbred ICR mice fed on high-
fat diet (HFD) and performed the paired associates learning (PAL) test to detect their visual memory and new learning ability loss 
as well as to assess memory impairment. The behavioral performance of the HFD mice was weaker than that of normal mice in the 
training but was not significantly associated with motivation. In the PAL test, the average number of trials completed and propor-
tion of correct touches was significantly lower in HFD mice than in normal diet-fed mice. Our results reveal that HFD-induced 
metabolic dysregulation has detrimental effects on operant learning according to the percentage of correct responses in PAL. These 
findings establish that HFD-induced metabolic stress may have an effect in accelerating AD-like pathogenesis.
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condition, leads to progressive cognitive decline and dementia. 
Classic AD pathology is characterized by extracellular amyloid 
beta (Aβ) plaques and intraneuronal deposits of neurofibrillary 
tangles (NFTs). NFTs are constituted by hyperphosphorylated tau 
proteins, whereas Aβ plaques are insoluble and an aggregated form 
of Aβ peptide [1]. However, recent studies have focused on the 
pathology of AD associated with the metabolic syndrome of obe-
sity [2], as clinical trials have failed with respect to drug candidates 
targeting amyloid pathways, such as beta-secretase inhibitors, 
gamma-secretase inhibitors, and Aβ itself [3]. 
The incidence of obesity is steadily increasing worldwide, and 
18% of adults were reported to be obese in 2014 [4]. Obesity is 
considered one of the greatest threats to human health [5] and is 
also associated with numerous risk factors, including physical in-
activity, genetic components, inflammation, blood lipid disorders, 
and insulin resistance. These common pathologies are associated 
with metabolic syndrome, which is a risk factor for neurological 
diseases [6, 7]. Therefore, the relationship between obesity and 
neurodegenerative diseases has been studied with focus on the 
probability that obesity may result in neurodegeneration, exacer-
bation of cognitive decline, and increased susceptibility to brain 
damage [8, 9]. Recently, obesity has been reported to be associated 
with not only an increased risk of mild cognitive impairment, but 
also late-life dementia and AD. The relative risk of dementia and 
AD in obese and overweight individuals compared with that in 
normal weight individuals was 2.04 and 1.64, respectively [10]. It 
remains unclear whether obesity alone is related with the risk of 
AD. Therefore, many researchers have evaluated cognitive func-
tion in mouse models through various behavioral tests. However, 
their studies did not precisely resemble the cognitive tasks used to 
examine humans. Recent developments in operant chamber tech-
nology, such as the touchscreen testing system, have resulted in an 
increased use of these automated systems with computerized data 
collection and analysis facilities; in addition to higher translational 
potential and increased reliability and accuracy, this has also led 
to the possibility of universal standard protocols across depart-
ments in institutions worldwide [11, 12]. Here, we assessed the 
performance of ICR mouse subjected to long-term HFD-feeding 
developing overweight and hyperglycemia, on touchscreen-based 
fixed ratio (FR) and progressive ratio (PR) schedules and paired-
associates learning (PAL) task, in order to examine motivational 
changes and cognitive impairment possibly associated with obe-
sity. We also attempted to determine the association between diet-
induced obesity and AD pathologies.
MATERIALS AND METHODS
Animals
Total 40 male ICR mice (age: 8 weeks; n=20/ND and 20/HFD; 
Central Lab Animal Inc., Seoul, Korea) were used in this study 
and maintained under a 12-h light/dark cycle with food and water 
ad libitum. One group was provided 60% high-fat diet (HFD; cat. 
no. D12492; Research Diets, New Brunswick, NJ, USA), while 
the other was provided normal diet (ND) with 4.8% of fat; both 
groups had free access to food and water. All animal experiments 
were approved by the Committee for the Care and Use of Labora-
tory Animals at Yonsei University Health System (2015-0039) and 
performed in accordance with the National Institute of Health 
guidelines for the Care and Use of Laboratory Animals.
Body weight and glucose level
Body weight and fasting blood glucose level were measured ev-
ery week. Mice were fasted for 4 hr before recording their glucose 
level. Blood samples were collected by cutting off the tip of the tail, 
and the glucose level was measured by a glucometer (CareSens II, 
Meter, Pharmaco Ltd.).
Glucose tolerance test
The glucose tolerance test is a widely used simple test in clini-
cal practice to diagnose glucose intolerance and type 2 diabetes. 
Mice were moved to another empty cage for overnight fasting 
(14 hr). Furthermore, 2 g/kg of glucose was dissolved in saline for 
intraperitoneal injection. Blood was collected from the tip of the 
tail, and measured with a glucometer at 0, 30, 60 and 120 min after 
the injection. The area under the concentration versus time curve 
(AUC glucose 0~120 min, mg/dl×minutes) was calculated and 
compared.
Insulin tolerance test 
Mice were fasted for 4 hr before the test, and 0.75 U/kg of insu-
lin was injected intraperitoneally into the subjects (dissolved in 
saline). Blood was collected from the tip of the tail, and measured 
with a glucometer at 0, 30, 60, and 120 min after the injection. The 
area under the concentration versus time curve (AUC glucose 
0~120 min, mg/dl×minutes) was calculated and compared.
Touchscreen-automated operant battery system
Testing was conducted in a Bussey-Saksida touchscreen-based 
automated operant system for all mice (Campden Instruments 
Ltd.), as detailed elsewhere [11, 12]. The apparatus consists of a 
standard modular testing chamber housed with a sound- and 
light-attenuating box. The 12-inch-wide touchscreen has a high 
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resolution (800×600) and is surrounded by a stainless-steel grid 
floor and trapezoidal acrylic wall. The inner chamber is surround-
ed by infrared beams, which detect animal movement. The front 
beam is located at 6 cm from the touchscreen, and the rear beam 
at 3 cm from the food magazine. Another infrared beam detects 
head entries to the food magazine. The head entry to the magazine 
indicates a trial initiation or an attempt to collect a reward. The 
magazine contains a light-emitting diode (LED), which is turned 
on when 20 μl of the reward is delivered and is turned off when the 
mouse collects the reward and exits from the magazine. At the op-
posite side of the magazine is a flat touchscreen monitor. A black 
plastic mask (Campden Instruments Ltd) is used to compartmen-
talize the screen. It has a row of 5 square (4×4 cm) holes, which 
are placed 1.5 cm above the floor. In FR and PR schedules, a visual 
stimulus only appears in the middle. For the PAL task, masks with 
3-square holes were used.
Touchscreen-based behavioral testing
FR/PR: To determine whether metabolic changes, includ-
ing overweight, affected the motivation of the animals, FR and 
PR schedules were conducted prior to the PAL task to evaluate 
memory. Procedures of FR/PR have been detailed elsewhere [13]. 
Because the test requires operant learning, which uses straw-
berry milk as a reward, animals’ body weights were maintained at 
85~90% of their average free-fed weight to ensure their motivation 
for food intake. To acclimate mice to the reward, a small quantity 
of strawberry milk was provided in their home cage with other 
food, and the mice were monitored for a full consumption for 3 
days to minimize neophobia. For 2 days habituation, mice were 
introduced to the chamber before the training. For 20 min, mice 
were exposed to the noise and house light in the chamber and 
removed thereafter. After the habituation, mice were subjected to 
the Initial Touch Training. After an intertrial interval (ITI; 5 sec), a 
white square was displayed in the center of the windows of the 5×1 
mask. The other grid positions were left blank. After 30 sec of de-
lay, the white image was removed, and reward was delivered with 
an illumination of the tray light and a 3-KHz tone for 1 sec. Entry 
to collect the reward turns off the tray light and starts the next ITI. 
If the mice touched the image on the screen while it was displayed, 
the image was removed, a tone was played with 3× reward deliv-
ered immediately. The completion of 30 trials in 60 min let the 
mice move on to the FR training. In the FR training, a white square 
was displayed in the center window of the 5×1 mask while the 
other grid positions are left blank. Upon completion of FR5 (five 
responses make one trial, which provides a single reward) training, 
animals underwent PR4 task.
PAL: The PAL task was performed as described thoroughly else-
where [14]. Briefly, mice first underwent pre-training, which con-
sisted of “initial touch”, “must touch”, “much initiate”, and “push blank 
touch” training. Subsequently, in the PAL training, two of three 
stimuli appeared on the screen. One stimulus was the correct one 
(S+) and another was the incorrect (S-). The other location was 
left blank without any stimulus. There were 6 possible trial types 
and 3 stimuli (flower, airplane, and spider). Each stimulus had a 
designated correct location, and animals were required to learn the 
paired association between the stimulus and location. A nose poke 
to the correct S+ stimulus resulted in a single bout of reward, that 
is, 200 μl of strawberry milk (Seoul Strawberry Milk®) with maga-
zine light on. A nose poke to the blank window was ignored. After 
20 sec of ITI, another trial was initiated. Each session ended when 
mice completed 36 trials in 60 min, whichever occurred first.
Tissue sample preparation
After behavior tests, mice were transcardially perfused with sa-
line. Whole brains were dissected at the cortex, hippocampus, and 
striatum and froze in liquid nitrogen, followed by storage at -80oC.
Immunoblotting
For immunoblotting, the cortex and hippocampus were treated 
with RIPA lysis buffer (Sigma) consisting of protease inhibitors 
mixture. Furthermore, 20 μg of protein was separated on 10% so-
dium dodecyl sulfate-polyacrylamide electrophoresis gels, electro-
transferred onto a polyvinylidene difluoride membrane (Milipore), 
and probed for the protein of interest by incubation with rabbit 
anti-Aβ1-42 fibril and mouse anti-β-actin (1:1000; Abcam) at 4oC 
overnight, followed by horseradish peroxidase-conjugated sec-
ondary antibodies (1:10000, Abcam) at room temperature for 90 
min. Signals were observed using enhanced chemiluminescence 
reagents (Thermo Fisher Scientific). Images were captured using 
the LAS 4000 program.
Transmission electron microscopy (TEM)
Samples was fixed for 12 hr in 2% glutaraldehyde–paraformalde-
hyde in 0.1 M phosphate buffer (PB; pH 7.4) and washed in 0.1 M 
phosphate buffer. They were post-fixed with 1% OsO4 dissolved in 
0.1 M PB for 2 hr and dehydrated in an ascending gradual series 
(50~100%) of ethanol and infiltrated with propylene oxide. Speci-
mens were embedded using Poly/Bed 812 kit (Polysciences). After 
pure fresh resin embedding and polymerization at 65oC, samples 
were put in the electron microscope oven (TD-700, DOSAKA) 
for 24 hr. Approximately 200–25-nm-thick sections were initially 
cut and stained with toluidine blue (Sigma, T3260) and observed 
under a light microscope. Furthermore, 70-nm-thin sections were 
double-stained with 6% uranyl acetate (EMS, #22400) for 20 min 
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and lead citrate (Fisher, for 10 min) for contrast staining. The sec-
tions were cut by LEICA EM UC-7 (Leica Microsystems) with a 
diamond knife (Diatome) and transferred on copper and nickel 
grids. All thin sections were observed through transmission elec-
tron microscopy (JEM-1011, JEOL) at an acceleration voltage of 
80 kV.
A Formvar-carbon coated EM grid was placed on top of the 
brain tissue drop for approximately 1 min. The grid was removed, 
blotted with a filter paper, and placed onto a drop of 2% uranyl ac-
etate for 15 s. The excess uranyl acetate was removed, and the EM 
grid was examined and photographed using transmission electron 
microscopy (JEM-1011, JEOL).
Hematoxylin and eosin staining
The eye specimen was fixed with 4% paraformaldehyde and em-
bedded with paraffin. Excised sections were roughly 5-μm thick. 
Sections were stained with hematoxylin and eosin (H&E; Muto, 
Japan).
Tonometry
Mice were anesthetized with an intraperitoneal injection of xyla-
zine (10 mg/kg; Rompun®, Bayer Animal Health) and zolazepam 
and tiletamine (30 mg/kg; Zoletil 50). Intraocular pressure (IOP) 
was measured using a rebound tonometer (Icare® TONOLAB 
tonometer, Colonial Medical Supply). IOP measurements were 
recorded according to the manufacturer’s instructions. One trial 
result was given after six consecutive measurements, and the mean 
of 10 consecutive trials was considered for analyses. Mouse phe-
notyping analysis was performed by Korea Mouse Phenotyping 
Center. 
Optical coherence tomography
After anesthesia, the pupils were dilated with 0.5% tropicamide 
and 0.5% phenylephrine-mixed eye drop (Mydrin-P, Santen Phar-
maceutical Co, Ltd.,). Optical coherence tomography (OCT) scans 
were obtained using Micron® IV (Phoenix Research Labs, Pleas-
anton, CA, USA). The cornea was lubricated with hypromellose 
2.5% (Goniovisc, Hub Pharmaceuticals), and mice were placed 
collaterally to the OCT camera on the right side of a platform 
fixed in front of the OCT lens. Subsequently, we focused on the 
retina and obtained fundus photography and OCT scans. Retinal 
thickness was measured using InSight—Animal OCT Segmenta-
tion Software (Phoenix Research Labs).
Electroretinogram
Electroretinogram (ERG) recordings were obtained using Mi-
cron Ganzfeld ERG (Phoenix Research Labs, Pleasanton). Mice 
were dark-adapted overnight for at least 12 hr before the experi-
ment for scotopic testing (rod cell response). After anesthesia, the 
pupils were dilated as previously described. Once the pupil was 
adequately dilated, we applied hypromellose 2.5% (Goniovisc) 
and inserted the electrodes. ERG was recorded as Ganzfeld ERG 
according to the standard protocol of the manual instruments. 
Scotopic ERGs were obtained in response to increasing flash in-
tensities, ranging from -1.7 log cd·s/m2 to 1.9 log cd·s/m2. Photopic 
ERGs were obtained in response to increasing flash intensities, 
ranging from -0.5 log cd·s/m2 to 4.1 log cd·s/m2. Ten responses 
to light stimulation were averaged. The a-wave (as a measure of 
photoreceptor function), b-wave (as a measure of bipolar cell 
function), and amplitude and implicit times of the rod and cone 
responses were determined.
Statistical analyses
All studies were randomized and assessments were performed by 
investigators blinded to the experimental conditions. All data were 
analyzed with standard statistical methods (t-test; Systat Software, 
Inc). Data are presented as the mean±standard error. Differences 
between the two groups were compared using an unpaired t-test, 
and multiple comparisons were performed using one-way ANO-
VA, followed by Bonferroni’s post hoctest. p≤0.05 was considered 
significant.
RESULTS
Long-term HFD feeding increased body weight and blood 
glucose level
Long-term HFD feeding resulted in a 1.5-fold higher body 
weight relative to ND (Fig. 1A). Blood glucose levels significantly 
increased in HFD mice compared with ND mice (Fig. 1B). How-
ever, independent of the elevated blood glucose level, HFD mice 
had no significant effect in either glucose tolerance or insulin re-
sistance (Fig. 1C~1F).
Metabolic dysregulation had no effect on the motivation 
level in HFD mice
In many neurodegenerative diseases and psychiatric disorders 
including AD, reduced motivation is observed. To assess motiva-
tion level and reward-related decision making, we used FR and PR 
paradigms [13]. Eight-week-old mice were randomly assigned to 
two groups and fed either a normal or high-fat diet for 12 weeks. 
After 2 weeks of weight regulation by chow deprivation, fixed and 
progressive ratio tests were conducted. At 27 weeks of feeding, 
mice started the PAL test and proceeded until 42 weeks before they 
were sacrificed. To learn the FR task for poking mice’s heads into 
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the food magazine, the body weight of feeding-controlled ND and 
HFD (ND and HFD ctrl) mice was reduced (about 10~15%) com-
pared with the average body weight (a.w.) of 12-week-old feeding-
free mice (Fig. 2B). Mice were first trained in FR1 (single touch in a 
trial to provide a single reward) and moved on to FR3, and to FR5 
(five correct touches in a trial). Sessions to Criteria, which indicates 
the number of sessions (days) required to achieve the criterion 
of each step, significantly differed between the groups; the HFD 
group needed more time to complete the training conducted from 
FR1 to FR5 (Fig. 2C). Upon completion of FR5 training, mice were 
transferred to PR4, and the behavioral performances in PR4 were 
measured by breakpoint, which indicates the number of responses 
in the last completed ratio condition. The average breakpoint of 
three sessions did not differ between the groups (Fig. 2D). The data 
indicate that motivation was not significantly affected by HFD, 
although instrumental (operant) learning in the FR schedule was 
slower in HFD mice than in ND mice.
Metabolic dysregulation induced learning impairment in 
HFD mice
To assess the cognitive changes affected by the HFD, we used the 
PAL paradigm. In the pre-training phase of the PAL task, HFD 
mice showed a slower progress than did the ND mice (Fig. 3A). In 
the PAL task, mice were trained to learn associations between the 
object (shape) and location. Despite 14 sessions of PAL training, 
most animals from both ND and HFD groups hardly completed 
all of the 36 trials in 60 min. We thought this reduced level of task 
engagement might be because of their age, high body weight, or 
perceptual (visual) disturbance. Thus, instead of continuing the 
training, we decided to use the last three sessions to present results 
of the PAL performance of these animals (Fig. 3B~D). As shown 
by the average session length, most animals did not complete the 
Fig. 1. Body weight and blood glucose level of 
ND and HFD mice. (A) Effect of HFD on body 
weight. Male ICR mice were fed an HFD supple-
ment for 12 weeks. (B) Weekly blood glucose lev-
els of ND and HFD mice measured from 8 to 20 
weeks of age. (C) Blood glucose levels during the 
intraperitoneal glucose tolerance test (IPGTT). 
(D) The area under the curve of the glucose dur-
ing the IPGTT. (E) Blood glucose levels during 
the intraperitoneal insulin tolerance test (IPITT). 
(F) The area under the curve of the glucose dur-
ing the IPITT (n=18/ND and 17/HFD; *p<0.05, 
†p<0.005, #p<0.001).
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36 trials within 60 min in these three sessions (Fig. 3B). The aver-
age number of trials completed was significantly lower for HFD 
mice (Fig. 3C). The percentage of correct touch (accuracy=correct 
responses divided by correct plus incorrect responses, %) was also 
significantly lower in HFD mice compared with ND mice, sug-
gesting HFD-induced learning impairment (Fig. 3D).
HFD led to decreased number of synapses and elevated Aβ 
fibril expression in mice
To explore structural changes in hippocampal neurons of HFD 
mice, we used electron microscopy and immunoblotting. The 
number of synapse in the hippocampus was significantly de-
creased and post-synaptic densities were thinned in HFD mice fed 
for 24 weeks (Fig. 4A). In the hippocampal synapses of ND mice, 
56±3%, 48.5±5%, and 38±4% were preserved in the CA1, CA3, and 
DG, respectively. HFD feeding significantly reduced the numbers 
of synapses in the CA1, CA3, and DG of hippocampus by 38±2%, 
27±1.5%, and 25±2% (Fig. 4B). To confirm the expression of Aβ 
Fig. 2. Performance of feeding-controlled ND and 
HFD mice in the progressive ratio 4 (PR4) sched-
ule. (A) Timeline of the behavioral study. (B) Body 
weight of ND and HFD mice after the food restric-
tion. (C) The number of sessions that met criteria 
for the fixed ratio (FR) training. (D) The mean PR4 
breakpoint of three consecutive sessions of test 
(n=13/ND and 16/HFD group; *p<0.05, **<0.005).
Fig. 3. Rate of training and response accuracy of ND and HFD mice in 
Paired-Associates Learning (PAL) schedules. (A) Performance of male 
ICR mice in PAL training for 60 minutes. (B) Average session length in 
the last 3 sessions of PAL task (Sessions ended in 60 min). (C) The aver-
age number of trials per session conducted in the last three sessions of the 
PAL task. (D) Accuracy in the last three sessions of the PAL task (n=7/ND 
and 11/HFD group; *p<0.05).
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after long-term HFD feeding in the mice brain, immunoblots were 
also performed. The expression of Aβ fibrils were increased in the 
cortex and hippocampus of HFD mice on 12 and 24 weeks (Fig. 
4C). These data support that the metabolic dysregulation by long-
term HFD feeding induces neuronal injury.
Long-term HFD mice had no change in visual acuity
Using touchscreen-automated battery system with visual 
stimulation, visual function was a critical issue. Visual tests were 
conducted to confirm that visual acuity was not affected by diet-
induced diabetes-like symptom, therefore, behavioral test result is 
solely based on the cognitive decline [15]. Tonometry data suggest 
no significant difference in intraocular pressure between ND and 
HFD mice, suggesting no chances for glaucoma (Fig. 5A). Mann–
Whitney tests showed no morphological difference either in the 
cornea or fundus between ND and HFD mice. The layer of their 
retina was also well-distinguished and showed the same ratio of 
IPL:INL:ONL-RPE (Fig. 5B). The morphological structure of the 
H&E-stained sections showed slight, but not significant swelling 
(Fig. 5C). In the retina of ND and HFD mice, the function of the 
rod and cone cell had no significant effect (Fig. 5D). Analysis of 
the A- and B-wave amplitude indicated that function and reaction 
latencies had no significant difference in photoreceptor cells of 
ND and HFD mice. Therefore, in ND and HFD mice, structures 
and functions of the cornea and retina were intact, and the func-
tion of photoreceptor cells also presented a normal state (Fig. 5E).
DISCUSSION
Our study demonstrates cognitive function failure induced by 
metabolic dysregulation in a rodent model. In the HFD group, 
the blood glucose level increased along with body weight gain, 
in a time-dependent manner; this group also showed difficulty 
in learning simple tasks. In support of the learning disability, the 
number synapse was reduced in the CA1, CA3, and DG of the 
hippocampus of HFD mice. On the other hand, Aβ expression in 
the cortex and hippocampus of HFD mice was increased com-
pared with that in the ND mice. 
The global prevalence of obesity is increasing. Obesity is an 
excessive accumulation of fat stored in adipose and non-adipose 
tissues as triglycerides that can be broken down into fatty acids, 
which can negatively affect health [16]. Obesity is an important 
factor for the development of metabolic disorders [17]; it has dam-
aging effects on many organ systems. Many complications and 
concurrent diseases are related to metabolic syndrome, character-
ized by a high weight, glucose intolerance, high triglyceride levels, 
Fig. 4. Synaptic morphology changes and Aβ fibril expression in ND and HFD mice. (A) TEM images of CA1, CA3, and DG in the hippocampus. In 
the high magnification (High Mag), the red triangles are pointing to the post synaptic density. (B) The numbers of synapse in TEM images. (C) Aβ fibril 
expression of the hippocampus and cortex in the ND and HFD groups at 12 and 24 weeks. Relative intensities of Aβ fibrils to β-actin in the hippocam-
pus and cortex (n=3/ND group and 3/HFD group; *p<0.05, **p<0.01, ***p<0.001).
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and hypertension and are thus risk factors for non-insulin-depen-
dent (type II) diabetes mellitus (T2DM), coronary artery diseases, 
systemic hypertension, and heart failure. Moreover, obesity is as-
sociated with the incidence of respiratory diseases such as obstruc-
tive sleep apnea, gastrointestinal and musculoskeletal disorders, 
thromboembolism, stroke, and cancer [18, 19]. In the past decade, 
it has been widely accepted that HFD leads to obesity that causes 
chronic low-grade inflammation followed by insulin resistance 
[17]. Subsequently, insulin resistance leads to hyperinsulinemia 
and β-cell failure successively, resulting in various metabolic dis-
orders, including type II diabetes and hepatic steatosis. However, 
in our study, HFD mice did not develop either glucose tolerance 
or insulin resistance, suggesting a prediabetic state than T2DM 
[20]. In this study, we investigated non-diabetic metabolic disease. 
Recently, obesity induced by metabolic syndrome is reported to 
be concurrent with AD, indicating that AD is a type of metabolic 
disease [21]. Therefore, metabolic alteration could be the potential 
cause of AD, such that various substances (insulin, adiponectin, 
and antioxidants) influenced by metabolic alterations could be a 
therapeutic target for AD. 
Recent epidemiological and clinical studies have indicated that 
Aβ deposition cannot satisfactorily explain AD development, and 
that dysregulation of glucose metabolism is a critical factor for the 
sporadic onset of the non-genetic, vast majority form of AD [22]. 
The development of AD treatment could benefit from considering 
the relationship between AD and obesity. Over the last decade, the 
population of obese people has increased in epidemic proportions. 
Therefore, the association between obesity and neurodegenerative 
diseases has been studied with focus on the probability that obesity 
may lead to neurodegeneration, exacerbation of cognitive decline, 
and increased susceptibility to brain damage [8, 9]. In this regard, 
numerous studies have shown that people with midlife obesity 
(measured by body mass index or central adiposity) have an 
augmented risk of AD [23]. According to previous studies, HFD 
increases hippocampal oxidative stress, which reduces NF-E2-
related factor 2 signaling [24], causes mitochondrial homeostasis 
deficiency [25], and impairs hippocampus-dependent memory 
function [26]. Therefore, measuring the impairment of cognitive 
function due to a HFD in an animal model, especially the hippo-
campus-dependent memory function, is crucial. The development 
Fig. 5. Visual test of ND and HFD mice. (A) Intraocular pressure of the ND and HFD groups. (B) The corneal and retinal morphology of the ND and 
HFD groups, and layer distribution of the retina measured on optical coherence tomography. (C) H&E staining of the retina. (D) Electroretinography of 
the ND and HFD groups showing light sensitivity of the rod cells, cone cells, and connecting ganglion cells of each mouse. (E) The quantification of the 
light sensitivity of the retina to the A- and B-wave and their response time (n=4/ND group and 4/HFD group).
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of robust and validated cognitive assays in mice is essential to fully 
capitalize on this species, which is increasingly used in neurobio-
logical investigations and as models of diseases involving the hip-
pocampus, such as schizophrenia and AD [27, 28]. However, the 
method of cognitive behavioral testing in animal models remains 
limited, mostly for measuring spatial cognitive ability. Trustworthy 
and reproducible analysis of animal learning and behavior is an 
important factor for basic and translational neuroscience research 
[29, 30]. Current advancement inoperant chamber technology, 
such as the touchscreen testing system, has resulted in the expend-
ing use of these automated systems with computerized data accu-
mulation and analysis facilities. Furthermore, higher translational 
potential and increased reliability and accuracy have contributed 
to the possibility of universal standard protocols across depart-
ments in institutions worldwide [11, 12, 31]. Thus, hippocampus-
dependent memory function changes caused by HFD were as-
sessed using touchscreen methods in this study. Behavioral testing 
of the animals using the touchscreen method showed that long-
term HFD did not affect motivation levels for feeding. This study 
shows that metabolic control disorders caused by HFDs do not af-
fect the level of motivation for experimental animal feeding. In the 
touchscreen behavioral test, HFD animals showed slow progress 
in the PAL training session. As the PAL training progressed slowly, 
long-term HFD was observed to influence the memory acquisi-
tion of mice. These results reveal that metabolic control disorder 
caused by HFD causes learning disorder. However, the animals 
used in this experiment were very old (age: 50 weeks) and were fed 
high fat for a long time at the completion of the behavioral test. In 
fact, animals were hardly engaged in the PAL task, as indicated by 
the incomplete sessions (Fig. 3B and C). This might be because of 
their old age, high body weights, or perceptual disturbances espe-
cially in visual ability. In this sense, despite collateral evidence on 
abnormalities in hippocampal neurons, our data from PAL tasks 
only indicate a nonspecific failure in operant learning itself rather 
than any particular form of learning (such as associates learning) 
in HFD mice as their PAL performance was even lower than the 
chance level (50%; Fig. 3D), in addition to their general difficulty 
observed in pre-training (Fig. 2C and 4A).
In order to rule out visual perception loss in HFD mice, the 
retina and visual function were examined. No structural or cellular 
difference was observed in the visual system of ND and HFD mice. 
The retina of HFD mice was slightly swollen, but the structure and 
functions of the cornea and retina were intact; photoreceptor cell 
function was also normal. Therefore, in this study, we investigated 
the cognitive functions of various areas of experimental animals in 
addition to spatial cognitive ability through behavioral screening 
using touchscreen methods.
Next, we investigated the expression of Aβ fibrils and changes 
in hippocampal neurons at the synapses in order to relate this 
deterioration of cognitive function caused by high-fat feeding to 
structural changes in neurodegenerative diseases such as AD. In 
our study, the number of axons was reduced and the expression 
of Aβ was increased in hippocampal neurons of the HFD mice. 
Long-term high fat intake also led to a loss of synapses. At 24 
weeks in the HFD group, the number of synapse per square area 
was significantly reduced; in particular, post-synaptic density was 
significantly reduced. These results suggest that this structural 
degradation may lead to a decrease in cognitive function.
Our results demonstrate that metabolic control disorders in-
duced by HFD result in an impairment in cognitive function in 
animals, and that this cognitive dysfunction is caused by the struc-
tural loss of the hippocampal neurons. These results suggest that 
HFD-induced metabolic stress may have an effect in accelerating 
pathogenesis of AD-like cognitive function.
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